9-137605774-C-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152285.4(ARRDC1):c.57C>A(p.Ser19Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000815 in 1,349,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000067 ( 0 hom. )
Consequence
ARRDC1
NM_152285.4 missense
NM_152285.4 missense
Scores
2
4
13
Clinical Significance
Conservation
PhyloP100: -0.0510
Genes affected
ARRDC1 (HGNC:28633): (arrestin domain containing 1) Enables several functions, including arrestin family protein binding activity; ubiquitin ligase-substrate adaptor activity; and ubiquitin protein ligase binding activity. Involved in several processes, including cellular protein metabolic process; extracellular vesicle biogenesis; and negative regulation of Notch signaling pathway. Located in cytoplasmic vesicle; extracellular vesicle; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14479208).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARRDC1 | NM_152285.4 | c.57C>A | p.Ser19Arg | missense_variant | 1/8 | ENST00000371421.9 | NP_689498.1 | |
ARRDC1 | NM_001317968.2 | c.57C>A | p.Ser19Arg | missense_variant | 1/7 | NP_001304897.1 | ||
ARRDC1 | XM_005266119.2 | c.57C>A | p.Ser19Arg | missense_variant | 1/7 | XP_005266176.1 | ||
ARRDC1 | XM_047424069.1 | c.57C>A | p.Ser19Arg | missense_variant | 1/8 | XP_047280025.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARRDC1 | ENST00000371421.9 | c.57C>A | p.Ser19Arg | missense_variant | 1/8 | 1 | NM_152285.4 | ENSP00000360475.4 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151806Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
151806
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000488 AC: 2AN: 41020Hom.: 0 AF XY: 0.0000800 AC XY: 2AN XY: 25000
GnomAD3 exomes
AF:
AC:
2
AN:
41020
Hom.:
AF XY:
AC XY:
2
AN XY:
25000
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000668 AC: 8AN: 1198004Hom.: 0 Cov.: 31 AF XY: 0.00000511 AC XY: 3AN XY: 587372
GnomAD4 exome
AF:
AC:
8
AN:
1198004
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
587372
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151914Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74242
GnomAD4 genome
AF:
AC:
3
AN:
151914
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74242
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.57C>A (p.S19R) alteration is located in exon 1 (coding exon 1) of the ARRDC1 gene. This alteration results from a C to A substitution at nucleotide position 57, causing the serine (S) at amino acid position 19 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Uncertain
D;T;T
Polyphen
P;P;P
Vest4
MutPred
Gain of methylation at S19 (P = 0.0264);Gain of methylation at S19 (P = 0.0264);Gain of methylation at S19 (P = 0.0264);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at